Hepatitis B prophylaxis among recipients of a hepatitis B core antibody positive liver transplant., PMID:36759305
HBcAb positivity increases the risk of postoperative complications after extended hemihepatectomy for hilar cholangiocarcinoma., PMID:36847156
Hepatitis B in Heart Transplant Donors and Recipients: A Systematic Review and Meta-Analysis., PMID:36914999
Antibodies to Hepatitis B core antigen prevalence study in Kazakhstan., PMID:36988253
Prevalence and awareness of Hepatitis B virus infection in the United States: January 2017 - March 2020., PMID:36996000
Transfusion-transmitted HBV infection with isolated anti-HBs-positive blood., PMID:37129363
Occult Hepatitis B Virus Infection and Liver Fibrosis in Chinese Patients., PMID:37170968
Hepatitis B Core Antibody Level: A Surrogate Marker for Host Antiviral Immunity in Chronic Hepatitis B Virus Infections., PMID:37243197
Cross-Reactivity of HBe Antigen-Specific Polyclonal Antibody with HBc Antigen., PMID:37294935
World Hepatitis day 2021 -screening and vaccination against Hepatitis B virus in Accra, Ghana., PMID:37328849
Atypical Hepatitis B Virus Serology Profile-Hepatitis B Surface Antigen-Positive/Hepatitis B Core Antibody-Negative-In Hepatitis B Virus/HIV Coinfected Individuals in Botswana., PMID:37515230
Development of Chimeric Hepatitis B (HBV) - Norovirus (NoV) P particle as candidate vaccine against Hepatitis B and norovirus infection., PMID:37519778
Expanding the donor pool: Kidney transplantation from serum HBV DNA or HBeAg-positive donors to HBsAg-negative recipients., PMID:37592870
Intranasal HBsAg/HBcAg-Containing Vaccine Induces Neutralizing Anti-HBs Production in Hepatitis B Vaccine Non-Responders., PMID:37766155
Marked reduction in the incidence of transfusion-transmitted hepatitis B virus infection after the introduction of antibody to hepatitis B core antigen and individual donation nucleic acid amplification screening in Japan., PMID:37767806
Ultrasensitive PCR system for HBV DNA detection: Risk stratification for occult hepatitis B virus infection in English blood donors., PMID:37796091
Expression and purification of Hepatitis B virus core antigen using Escherichia coli and its utilization for the diagnosis of Hepatitis B virus infections., PMID:37979341
Predictive value of hepatitis B serological indicators for mortality among cancer survivors and validation in a gastric cancer cohort., PMID:38150459
Seroreactivity of antibodies to hepatitis B core antigen among hepatitis B surface antigen-screened negative blood donors and its implications for blood safety in a resource-constrained country., PMID:38245853
Suggested blood donor deferral strategy regarding hepatitis B infections in China., PMID:38258949
Breakthrough infection by hepatitis B virus in a vaccinated blood donor: An emerging threat for transfusion safety in low-endemic countries?, PMID:38345135
A case-control study of risk factors for incident hepatitis B virus infection in South African blood donors., PMID:38373648
De novo hepatitis B infection following liver transplantation with core antibody positive grafts: The role of surface antibody status in guiding long-term prophylaxis., PMID:38375953
Biomarkers of transfusion transmitted occult hepatitis B virus infection: Where are we and what next?, PMID:38375981
Blood donation screening for hepatitis B virus core antibodies: The importance of confirmatory testing and initial implication for rare blood donor groups., PMID:38419267
Early application of IFNγ mediated the persistence of HBV in an HBV mouse model., PMID:38556058
Impact of Hepatitis B Surface and Core Antibody Levels on Hepatitis B Virus Reactivation., PMID:38735754
Low Prevalence of Anti-HBc Antibody and Lack of HBV DNA Among HBsAg-Negative Blood Donors in Iran: A Cross-sectional Study and Review of Literature., PMID:38855800
Hepatitis B transmission/reactivation associated with Hepatitis B core antibody and Hepatitis C nucleic acid testing positive organs: A report from the Organ Procurement and Transplantation Network Disease Transmission Advisory Committee., PMID:38881210
Varied immune responses of HBV-specific B cells in patients undergoing pegylated interferon-alpha treatment for chronic hepatitis B., PMID:38992769
Incidences of new hepatitis B infection and anti-hepatitis B core-negative occult hepatitis B infection among Japanese blood donors in relation to anti-hepatitis B surface antigen levels., PMID:39039862
Ex Vivo Fluorescent Labeling of HBV-Specific B Cells in Chronic Hepatitis B Patients., PMID:39044090
Quantitative HBV Core Antibodies as a Prognostic Marker for HBeAg Seroclearance: A Systematic Review with Meta-Analysis., PMID:39066283
Anti-HBc mirrors the activation of HBV-specific CD8+ T cell immune response and exhibits a direct effect on HBV control., PMID:39089333
What is the benefit of prophylaxis to prevent HBV reactivation in HBsAg-negative anti-HBc-positive patients? Meta-analysis and decision curve analysis., PMID:39206573
International review of blood donation screening for anti-HBc and occult hepatitis B virus infection., PMID:39359112
Survival after liver transplantation from hepatitis B-core positive donors at a quaternary care hospital in Brazil., PMID:39401751
Kinetics of hepatitis B virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to tenofovir sparing therapy., PMID:39505254
The characterization and structural basis of a human broadly binding antibody to HBV core protein., PMID:39601613
Obtaining HBV core protein VLPs carrying SARS-CoV-2 nucleocapsid conserved fragments as vaccine candidates., PMID:39609857
Early HBcrAg and Anti-HBc Levels Identify Patients at High Risk for Severe Flares After Nucleos(t)ide Analogue Cessation-A Pooled Analysis of Two Clinical Trials., PMID:39624922
Functional B cell deficiency promotes intrahepatic HBV replication and impairs the development of anti-HBV T cell responses., PMID:39630171
Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation., PMID:39638038
Design of multi-epitope-based therapeutic vaccine candidates from HBc and HBx proteins of hepatitis B virus using reverse vaccinology and immunoinformatics approaches., PMID:39642099
Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus Infection., PMID:39846714
A cell-penetrating bispecific antibody suppresses hepatitis B virus replication and secretion., PMID:39863173
Molecular and serological investigation of hepatitis B virus in patients with acute undifferentiated febrile illness at Tha Song Yang hospital, Tak Province, Thailand., PMID:39891087
Detection of hepatitis B virus surface antigen, IgM and IgG antibodies to hepatitis B virus core antigen in the clinical classification and epidemiological surveillance of HBV infection., PMID:39903324
Serum levels of hepatitis B core antibodies and hepatitis B core-related antigen at the time of nucleos(t)ide analog cessation and risk of severe flares in patients with chronic hepatitis B., PMID:40008890
Performance evaluation of the access anti-HBc IgM Assay on the DxI 9000 access immunoassay analyzer., PMID:40305958
For research use only. Not for human or drug use.
